U5P.F VIVANI MED.INC. NEW O.N.

Healthcare Biotechnology Frankfurt Exchange
0.9300 EUR
Close of Nov 12, 2026
0.7350 1.27
Market cap
EUR 83.9M
P/E
-
P/B
5.10x
ROE
-138.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is U5P.F undervalued?

Graham number

The Graham number of VIVANI MED.INC. NEW O.N. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

VIVANI MED.INC. NEW O.N. fundamental analysis

No fundamental analysis for VIVANI MED.INC. NEW O.N. yet.

VIVANI MED.INC. NEW O.N. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About VIVANI MED.INC. NEW O.N.

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight m…

Full company profile